KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Workiva (WK) Asset Writedowns and Impairment (2016 - 2025)

Workiva (WK) has disclosed Asset Writedowns and Impairment for 12 consecutive years, with $72000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 15.29% to $72000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$214000.0 through Dec 2025, down 648.72% year-over-year, with the annual reading at -$214000.0 for FY2025, 648.72% down from the prior year.
  • Asset Writedowns and Impairment hit $72000.0 in Q4 2025 for Workiva, up from $59000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $353000.0 in Q4 2023 to a low of -$357000.0 in Q2 2025.
  • Historically, Asset Writedowns and Impairment has averaged $13300.0 across 5 years, with a median of $20000.0 in 2022.
  • Biggest five-year swings in Asset Writedowns and Impairment: soared 612.5% in 2024 and later plummeted 1885.0% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $37000.0 in 2021, then surged by 100.0% to $74000.0 in 2022, then soared by 377.03% to $353000.0 in 2023, then crashed by 75.92% to $85000.0 in 2024, then dropped by 15.29% to $72000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for WK at $72000.0 in Q4 2025, $59000.0 in Q3 2025, and -$357000.0 in Q2 2025.